Selon Health Canada (via FOI), ce/cet/cette rappel concerne un dispositif en/au/aux/à Canada qui a été fabriqué par MEDTRONIC OF CANADA LTD..

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
  • ID de l'événement
  • Classe de risque de l'événement
  • Date de mise en oeuvre de l'événement
  • Pays de l'événement
  • Source de l'événement
  • Notes / Alertes
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Notes supplémentaires dans les données
  • Cause
    Medtronic xomed is expanding the original product safety advisory for medtronic external nasal splints and thermasplints (incident 62165) to advise consignees to immediately discontinue using and dispose of the skin-prep protective wipes packed together with the affected medtronic nasal splint kits.The smith & nephew skin-prep protective wipes are contract manufactured by the triad group in the same facility where the alcohol wipes subject to the original field action are manufactured.


  • Modèle / numéro de série
    Model Catalog: 1529120 (Lot serial: ); Model Catalog: 1529110 (Lot serial: ); Model Catalog: 1528116 (Lot serial: ); Model Catalog: 1528126 (Lot serial: ); Model Catalog: 1528136 (Lot serial: ); Model Catalog: 1529100 (Lot serial: )
  • Description du dispositif
    SKIN-PREP Protective Wipes
  • Manufacturer


  • Adresse du fabricant
  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source